D.N. Stephens

2.4k total citations
34 papers, 1.0k citations indexed

About

D.N. Stephens is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, D.N. Stephens has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in D.N. Stephens's work include Neuroscience and Neuropharmacology Research (15 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Neuroendocrine regulation and behavior (5 papers). D.N. Stephens is often cited by papers focused on Neuroscience and Neuropharmacology Research (15 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Neuroendocrine regulation and behavior (5 papers). D.N. Stephens collaborates with scholars based in United Kingdom, United States and Australia. D.N. Stephens's co-authors include L.J. Herberg, L. Turski, Keith B.J. Franklin, Herbert H. Schneider, Adrian Davis, Tamzin L. Ripley, T. Honoré, W. Kehr, Theodora Duka and Hasso von Wedel and has published in prestigious journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

D.N. Stephens

34 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.N. Stephens United Kingdom 16 507 482 212 139 128 34 1.0k
M. Waldo United States 9 437 0.9× 525 1.1× 639 3.0× 23 0.2× 36 0.3× 16 1.5k
Kazutoyo Inanaga Japan 22 611 1.2× 525 1.1× 366 1.7× 18 0.1× 40 0.3× 124 2.0k
Lawrence E. Adler United States 13 484 1.0× 547 1.1× 715 3.4× 15 0.1× 52 0.4× 13 1.6k
Sumie Leung Australia 19 150 0.3× 581 1.2× 59 0.3× 35 0.3× 47 0.4× 30 914
A.M. Shelley United States 16 320 0.6× 1.5k 3.1× 146 0.7× 31 0.2× 86 0.7× 24 1.9k
Den’etsu Sutoo Japan 18 457 0.9× 268 0.6× 240 1.1× 12 0.1× 27 0.2× 66 1.2k
Kenneth Grasing United States 18 412 0.8× 322 0.7× 250 1.2× 16 0.1× 19 0.1× 52 1.0k
Beth L. Murphy United States 11 815 1.6× 639 1.3× 368 1.7× 16 0.1× 17 0.1× 11 1.6k
Marie‐Laure Paillère Martinot France 21 309 0.6× 956 2.0× 112 0.5× 81 0.6× 18 0.1× 32 1.8k
Mark J. Majchrzak United States 22 690 1.4× 299 0.6× 907 4.3× 15 0.1× 49 0.4× 47 1.6k

Countries citing papers authored by D.N. Stephens

Since Specialization
Citations

This map shows the geographic impact of D.N. Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.N. Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.N. Stephens more than expected).

Fields of papers citing papers by D.N. Stephens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.N. Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.N. Stephens. The network helps show where D.N. Stephens may publish in the future.

Co-authorship network of co-authors of D.N. Stephens

This figure shows the co-authorship network connecting the top 25 collaborators of D.N. Stephens. A scholar is included among the top collaborators of D.N. Stephens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.N. Stephens. D.N. Stephens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duka, Theodora, Robert Malcolm, Tamzin L. Ripley, et al.. (2004). Consequences of Multiple Withdrawals From Alcohol. Alcoholism Clinical and Experimental Research. 28(2). 233–246. 105 indexed citations
2.
Ripley, Tamzin L., Michael O’Shea, & D.N. Stephens. (2003). Repeated withdrawal from ethanol impairs acquisition but not expression of conditioned fear. European Journal of Neuroscience. 18(2). 441–448. 38 indexed citations
3.
Sanchez, Linnett & D.N. Stephens. (2002). Survey of the perceived benefits and shortcomings of a specialist tinnitus clinic.. PubMed. 39(6). 333–9. 15 indexed citations
4.
Stephens, D.N., et al.. (2001). Definitions, Protocols and Guidelines in Genetic Hearing Impairment. 22 indexed citations
5.
Bergman, Jack, Charles P. France, S G Holtzman, et al.. (2000). Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABA A -ergic ligands. Psychopharmacology. 153(1). 67–84. 39 indexed citations
6.
Smith, J. W., et al.. (1999). The calcium channel antagonist, nimodipine, decreases operant self-administration of low concentrations of ethanol. Behavioural Pharmacology. 10(8). 793–802. 11 indexed citations
7.
Zhao, Fu & D.N. Stephens. (1998). Analysis of Audioscan and DPOAEs in subjects with normal hearing. Bristol Research (University of Bristol). 37. 335–343. 5 indexed citations
8.
Stephens, D.N.. (1995). BEHAVIOURAL PHARMACOLOGY OF AMPA ANTAGONISTS. Behavioural Pharmacology. 6(5). 633–633. 1 indexed citations
9.
Schneider, Herbert H., et al.. (1993). Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.. Journal of Pharmacology and Experimental Therapeutics. 264(3). 1395–1400. 39 indexed citations
10.
Pribilla, I., et al.. (1993). Abecarnil is a Full Agonist at Some, and a Partial Agonist at Other Recombinant GABAA Receptor Subtypes. PubMed. 11. 50–61. 28 indexed citations
11.
Turski, L. & D.N. Stephens. (1993). Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam.. Journal of Pharmacology and Experimental Therapeutics. 267(3). 1215–1220. 16 indexed citations
12.
Coenen, A.M.L., D.N. Stephens, & E.L.J.M. van Luijtelaar. (1992). Effects of the β-carboline abecar on epileptic activity, EEG sleep and behavior of rats. Pharmacology Biochemistry and Behavior. 42(3). 401–405. 12 indexed citations
13.
Davis, Adrian, et al.. (1992). Hearing impairments in middle age: The acceptability, benefit and cost of detection (ABCD). British Journal of Audiology. 26(1). 1–14. 35 indexed citations
14.
Stephens, D.N., Herbert H. Schneider, W. Kehr, et al.. (1990). Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.. Journal of Pharmacology and Experimental Therapeutics. 253(1). 334–343. 112 indexed citations
15.
Sarter, Martin & D.N. Stephens. (1989). Disinhibitory properties of β-carboline antagonists of benzodiazepine receptors: a possible therapeutic approach for senile dementia?. Biochemical Society Transactions. 17(1). 81–83. 8 indexed citations
16.
Stephens, D.N., W. Kehr, & Th. Duka. (1986). Anxiolytic and anxiogenic beta-carbolines: tools for the study of anxiety mechanisms.. PubMed. 41. 91–106. 10 indexed citations
17.
Rothwell, Nancy J., D.N. Stephens, & Michael J. Stock. (1982). Changes in Metabolic Rate and Brown Adipose Tissue Composition during Nutritional Rehabilitation of Postnatally Undernourished Rats. Neonatology. 42(1-2). 93–99. 7 indexed citations
18.
Stephens, D.N. & L.J. Herberg. (1979). Dopamine-acetylcholine “balance” in nucleus accumbens and corpus striatum and its effect on hypothalamic self-stimulation. European Journal of Pharmacology. 54(4). 331–339. 21 indexed citations
20.
Herberg, L.J., D.N. Stephens, & Keith B.J. Franklin. (1976). Catecholamines and self-stimulation: Evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine. Pharmacology Biochemistry and Behavior. 4(5). 575–582. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026